Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05879978
Title A Study to Test How Well Different Doses of BI 764532 in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA | DEU | BEL

Facility Status City State Zip Country Details
Brussels - UNIV Saint-Luc RECRUITING Bruxelles 1200 Belgium Details
UNIV UZ Gent RECRUITING Gent 9000 Belgium Details
HOP Louis Pradel RECRUITING Bron 69677 France Details
CTR François Baclesse RECRUITING Caen 14000 France Details
INS Claudius Regaud IUCT-Oncopole RECRUITING Toulouse 31059 France Details
Universitätsklinikum Carl Gustav Carus Dresden RECRUITING Dresden 01307 Germany Details
Universitätsklinikum Frankfurt RECRUITING Frankfurt 60590 Germany Details
National Cancer Center Hospital RECRUITING Tokyo, Chuo-ku 104-0045 Japan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field